Procalcitonin for Antimicrobial Stewardship Among Cancer Patients Admitted with COVID-19
Hiba Dagher, View ORCID ProfileAnne-Marie Chaftari, Patricia Mulanovich, Ying Jiang, Ray Hachem, Alexandre E. Malek, Jovan Borjan, George M. Viola, Issam Raad
doi: https://doi.org/10.1101/2022.07.13.22277580
Hiba Dagher
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Anne-Marie Chaftari
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Patricia Mulanovich
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Ying Jiang
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Ray Hachem
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Alexandre E. Malek
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Jovan Borjan
2Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
George M. Viola
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Issam Raad
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Article usage
Posted July 15, 2022.
Procalcitonin for Antimicrobial Stewardship Among Cancer Patients Admitted with COVID-19
Hiba Dagher, Anne-Marie Chaftari, Patricia Mulanovich, Ying Jiang, Ray Hachem, Alexandre E. Malek, Jovan Borjan, George M. Viola, Issam Raad
medRxiv 2022.07.13.22277580; doi: https://doi.org/10.1101/2022.07.13.22277580
Procalcitonin for Antimicrobial Stewardship Among Cancer Patients Admitted with COVID-19
Hiba Dagher, Anne-Marie Chaftari, Patricia Mulanovich, Ying Jiang, Ray Hachem, Alexandre E. Malek, Jovan Borjan, George M. Viola, Issam Raad
medRxiv 2022.07.13.22277580; doi: https://doi.org/10.1101/2022.07.13.22277580
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12603)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4476)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2867)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4233)
- Nursing (226)
- Nutrition (619)
- Oncology (2218)
- Ophthalmology (630)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6818)
- Radiology and Imaging (1502)
- Respiratory Medicine (907)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)